XML 31 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Nature of Operations and Summary of Significant Accounting and Reporting Policies (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Apr. 20, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Jun. 30, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized 100,000,000 400,000,000   400,000,000   400,000,000
Common stock, par value $ 0.001 $ 0.001   $ 0.001   $ 0.001
Preferred stock, shares authorized 1,500,005 1,500,005   1,500,005    
Reverse stock split one-for-two hundred and fifty (1:250)          
Cash equivalents      
Value added tax receivable   4,386   4,386   $ 8,111
Research and development expense   1,034,729 $ 167,202 1,598,468 $ 328,399  
Research and development tax credit   $ 180,278 $ 180,278  
Employee Stock Option [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount       572,000    
Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount       149,517    
Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount       47,599,059    
Minimum [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized   100,000,000   100,000,000    
Maximum [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized   400,000,000   400,000,000